No results for ‘’
Evoq Remedies Ltd
₹1.52
(0.65%)
Mon, 05 Oct 2026, 00:50 pm
Health Technology
Pharmaceuticals: Major
24.5KEvoq Remedies Price to Cash Flow Ratio
No Result Found
| Particulars |
|---|
| Price to earnings ratio |
| Price to book ratio |
| Price to sales ratio |
| Price to cash flow ratio |
| Enterprise value |
| Enterprise value to EBITDA ratio |
| Debt to equity ratio |
| Return on equity % |
Evoq Remedies Ltd Price to Cash Flow Ratio
The Evoq Remedies Ltd Price to Cash Flow Ratio is a key financial metric used by investors to evaluate Evoq Remedies Ltd's valuation, profitability, and overall financial performance. Tracking the Evoq Remedies Ltd Price to Cash Flow Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Evoq Remedies Ltd (NSE: , BSE: 543500) is currently trading at ₹1.52, with a market capitalization of ₹0. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Evoq Remedies Ltd Price to Cash Flow Ratio is essential for fundamental analysis.
Evoq Remedies Ltd Price to Cash Flow Ratio Current Value
The current Evoq Remedies Ltd Price to Cash Flow Ratio stands at 0.
The Evoq Remedies Ltd Price to Cash Flow Ratio remains stable, indicating consistent financial performance.
Evoq Remedies Ltd Price to Cash Flow Ratio Historical Trend
The Evoq Remedies Ltd Price to Cash Flow Ratio has shown the following historical trend:
The decline in Evoq Remedies Ltd Price to Cash Flow Ratio indicates improving financial efficiency or better earnings growth.
What Evoq Remedies Ltd Price to Cash Flow Ratio Indicates for Investors
The Evoq Remedies Ltd Price to Cash Flow Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/CF ratio indicates how much investors pay for company cash flow.
Evoq Remedies Ltd Price to Cash Flow Ratio Analysis Summary
The Evoq Remedies Ltd Price to Cash Flow Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Evoq Remedies Ltd Price to Cash Flow Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Evoq Remedies Ltd Price to Cash Flow Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.